Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyBCTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyBCTeam Member asked a question 💭
Rochester, NY

Australian scientists at QIMR Berghofer have discovered a new RNA molecule that specifically targets and destroys hormone receptor positive breast cancer cells, which account for 70% of all breast cancers. The molecule showed remarkable results in laboratory testing, completely eliminating advanced breast tumour cells within hours while leaving normal cells unharmed. This world-first discovery offers hope for treating drug-resistant and non-responding advanced breast cancers, particularly for… read more

February 3
 · 
Reactions

Answer Summary

Members responded warmly to news about an Australian discovery of an RNA molecule that targets hormone receptor positive breast cancer cells,... Read more

Members responded warmly to news about an Australian discovery of an RNA molecule that targets hormone receptor positive breast cancer cells, expressing gratitude for the hopeful update and excitement about potential future treatment options. Several members shared personal connections to the research, including one member who has about a year left before her current AI treatment loses effectiveness and finds reassurance in knowing new options are emerging. A recurring theme was collective hope and encouragement, with members describing the breakthrough as uplifting and expressing wishes that it could be fast-tracked to help patients in urgent need.

MyBCTeam

What are the implications of this new RNA molecule discovery for hormone receptor-positive breast cancer treatment?

This is exciting news! The discovery of an RNA molecule that specifically targets hormone receptor-positive breast cancer cells represents a promising development, especially for those facing drug-resistant Show Full Answer

What are the implications of this new RNA molecule discovery for hormone receptor-positive breast cancer treatment?

This is exciting news! The discovery of an RNA molecule that specifically targets hormone receptor-positive breast cancer cells represents a promising development, especially for those facing drug-resistant or treatment-resistant cancers.

Currently, hormone receptor-positive breast cancers are typically treated with hormonal therapies like tamoxifen or aromatase inhibitors, which work by blocking hormones that fuel cancer growth. When these treatments stop working, options include chemotherapy or newer targeted therapies.

This new RNA molecule could potentially offer an alternative for patients whose cancers have stopped responding to standard treatments. The fact that it showed the ability to eliminate cancer cells while sparing healthy cells in laboratory testing is particularly encouraging, as this could mean fewer side effects compared to traditional chemotherapy.

However, it's important to remember this is still in early laboratory stages. The path from laboratory success to approved treatment involves extensive clinical trials to confirm safety and effectiveness in humans. If you're currently dealing with treatment-resistant breast cancer, talk with your oncologist about all available options and whether clinical trials might be appropriate for your situation.

February 3
A MyBCTeam Member

Good morning Sue10. À lot breakthroughs are coming and it's wonderful. Thank you for sharing 💕👍

February 4
A MyBCTeam Member

Awesome news!

February 8
A MyBCTeam Member

Thanks for this update.

February 4
A MyBCTeam Member

So glad you shared this information. Very interesting!

February 4

Related Questions

View All
A MyBCTeam Member asked a question 💭
Victoria, BC

A MyBCTeam Member asked a question 💭
Miami, AZ